L-Threonic acid-1,4-lactone

CAS : 21730-93-8

Ref. 3D-MT08297

Informations sur le produit

• Nom: L-Threonic acid-1,4-lactone
• Synonymes: L-Threonolactone, (3R,4S)-Dihydro-3,4-dihydroxy-2(3H)-furanone, 2(3H)-Furanone, dihydro-3,4-dihydroxy-, (3R,4S)-, 2(3H)-Furanone, dihydro-3,4-dihydroxy-, (3R-trans)-, 2(3H)-furanone, dihydro-3,4-bis[(trimethylsilyl)oxy]-, 21730-93-8, 3,4-Bis[(trimethylsilyl)oxy]dihydro-2(3H)-furanone, 3,4-bis[(trimethylsilyl)oxy]dihydro-cis-2(3H)-furanone, <span class="text-smallcaps">L</span>-Threonic acid, γ-lactone, <span class="text-smallcaps">L</span>-Threono-γ-lactone, <span class="text-smallcaps">L</span>-Threonolactone, Threonic acid, γ-lactone, <span class="text-smallcaps">L</span>-

Description

L-Threonic acid-1,4-lactone is a nutrient solution for mammalian tissue. It is a coenzyme that acts as an intermediate in the conversion of dehydroascorbic acid to erythronate and participates in the synthesis of 4-hydroxycinnamic acid from 4-hydroxyphenylpyruvic acid. L-Threonic acid-1,4-lactone has been shown to inhibit the replication of human immunodeficiency virus (HIV) in vitro. The physiological levels of L-Threonic acid-1,4-lactone are not yet known, but it has been shown to have inhibitory properties on HIV infection at concentrations that do not affect cellular metabolism or induce reactive oxygen species production. L-Threonic acid-1,4-lactone also has been shown to prevent hepatic steatosis and fatty liver disease by inhibiting lipid accumulation via its ability to

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 118.09 g/mol
• Formule: C₄H₆O₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder